Terms: = Kidney tumors AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Diagnosis
158 results:
1. The Prevalence and Radiologic Features of Renal Cancers Associated with
Charbel C; Causa Andrieu PI; Soliman M; Woo S; Zheng J; Capanu M; Nikolovski I; Vargas HA; Abusamra M; Carlo MI
Radiol Imaging Cancer; 2024 Mar; 6(2):e230063. PubMed ID: 38456787
[TBL] [Abstract] [Full Text] [Related]
2. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
[TBL] [Abstract] [Full Text] [Related]
3. The Predictive Power of Bosniak 3 and 4 Cystic Renal Lesion Categorization Using Contrast-Enhanced Ultrasound.
Járay Á; Farkas PI; Semjén D; Botz B
J Ultrasound Med; 2024 May; 43(5):933-949. PubMed ID: 38284141
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
[TBL] [Abstract] [Full Text] [Related]
5. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
6. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
Yang Y; Lee J; Woo CG; Lee OJ; Son SM
Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes of Head and Neck Free Tissue Transfer in Renal Failure Patients.
Oglesby KR; Jefferson GD; Thomas CM; Tomblin C; Alnemri A; Curry JM; Bonaventure C; Sweeny L; Richards HW; Wax M; Kane AC
Laryngoscope; 2024 Feb; 134(2):688-694. PubMed ID: 37449944
[TBL] [Abstract] [Full Text] [Related]
8. Examining the Evidence for Escalating Antimicrobial Regimens in Febrile Oncology and Hematopoietic Stem Cell Transplant Patients Admitted to the PICU: An Observational Study.
Prince RD; Blumenthal JA; Geva A
Pediatr Crit Care Med; 2023 Jun; 24(6):e292-e296. PubMed ID: 37036203
[TBL] [Abstract] [Full Text] [Related]
9. Non-obstructive jaundice as paraneoplastic syndrome of prostate carcinoma: Systematic review of published cases.
Santandreu-Morales I; Redondo-Cerezo E; Martín-Enguix D
Med Clin (Barc); 2023 Mar; 160(5):206-212. PubMed ID: 36526448
[TBL] [Abstract] [Full Text] [Related]
10. Utility of genetic work-up for 46, XY patients with severe hypospadias.
Srivastava P; Tenney J; Lodish M; Slavotinek A; Baskin L
J Pediatr Urol; 2023 Jun; 19(3):261-272. PubMed ID: 36496321
[TBL] [Abstract] [Full Text] [Related]
11. NFE2L3 as a Potential Functional Gene Regulating Immune Microenvironment in Human kidney Cancer.
Zhang Q; Tang D; Zha A; He J; Li D; Chen Y; Cai W; Dai J; Luan S; Yin L; Zhang W; Dai Y
Biomed Res Int; 2022; 2022():9085186. PubMed ID: 36337840
[TBL] [Abstract] [Full Text] [Related]
12. Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial.
Papachristofilou A; Bedke J; Hayoz S; Schratzenstaller U; Pless M; Hentrich M; Krege S; Lorch A; Aebersold DM; Putora PM; Berthold DR; Zihler D; Zengerling F; Dieing A; Mueller AC; Schaer C; Biaggi C; Gillessen S; Cathomas R
Lancet Oncol; 2022 Nov; 23(11):1441-1450. PubMed ID: 36228644
[TBL] [Abstract] [Full Text] [Related]
13. A nomogram integrating ferroptosis-and immune-related biomarker for prediction of prognosis and diagnosis in kidney renal clear cell carcinoma.
Xing XL; Liu Y; Liu JH; Zhou HF; Zhang HR; Zuo Q; Bu P; Duan T; Zhou Y; Xiao ZQ
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6176-6186. PubMed ID: 36111917
[TBL] [Abstract] [Full Text] [Related]
14. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
15. Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated kidney Cancer.
Zengin ZB; Pal SK; McDermott DF; Escudier B; Hutson TE; Porta C; Verzoni E; Atkins MB; Kasturi V; Rini B
Clin Genitourin Cancer; 2022 Dec; 20(6):553-557. PubMed ID: 36096984
[TBL] [Abstract] [Full Text] [Related]
16. Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.
Villagrán-García M; Muñiz-Castrillo S; Ciano-Petersen NL; Vogrig A; Farina A; Villard M; Psimaras D; Alentorn A; Gonçalves D; Fabien N; Rogemond V; Joubert B; Honnorat J
J Neurol; 2023 Jan; 270(1):283-299. PubMed ID: 36050418
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy of Cabozantinib in metastatic MiT Family Translocation Renal Cell Carcinomas.
Thouvenin J; Alhalabi O; Carlo M; Carril-Ajuria L; Hirsch L; Martinez-Chanza N; Négrier S; Campedel L; Martini D; Borchiellini D; Chahoud J; Lodi M; Barthélémy P; Hasanov E; Hahn AW; Gil T; Viswanathan SR; Bakouny Z; Msaouel P; Asim Bilen M; Choueiri TK; Albiges L; Tannir NM; Malouf GG
Oncologist; 2022 Dec; 27(12):1041-1047. PubMed ID: 35979929
[TBL] [Abstract] [Full Text] [Related]
18. National outcomes following benign cardiac tumor resection: A critical sex-based disparity.
Newell P; Zogg CK; Kusner J; Hirji S; Kerolos M; Kaneko T
J Card Surg; 2022 Sep; 37(9):2653-2660. PubMed ID: 35662249
[TBL] [Abstract] [Full Text] [Related]
19. [Analysis of phenotype and FH gene variation in a pedigree affected with hereditary leiomyomatosis and renal cell carcinoma syndrome].
Guo Y; Wang L; Xu Z; Bai Y; Wang W; Wu H; Sun Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):494-498. PubMed ID: 35598264
[TBL] [Abstract] [Full Text] [Related]
20. Artificial Intelligence in kidney Cancer.
Rasmussen R; Sanford T; Parwani AV; Pedrosa I
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-11. PubMed ID: 35580292
[TBL] [Abstract] [Full Text] [Related]
[Next]
